Table 5. Univariate and multivariate predictors of mortality on stepwise logistic regression analysis.
HE, hepatic encephalopathy; MELD Na, model for end-stage liver disease sodium; SOFA, sequential organ failure assessment score; INR, international normalized ratio; AKI, acute kidney injury; TLC, total leukocyte count; qSOFA, quick SOFA
| Mortality | Univariate | P value | Multivariate | P value |
| Age | 0.99 (0.97-1.01) | 0.54 | ||
| Female gender | 1.61 (0.73-3.57) | 0.23 | ||
| Alcohol vs. other etiology | 1.28 (0.8-2.04) | 0.28 | ||
| HE | 1.41 (0.9-2.23) | 0.13 | ||
| MELD Na | 1.11 (1.07-1.14) | <0.001 | 1.08 (1.05-1.12) | <0.001 |
| H/o norfloxacin prophylaxis | 1 (0.58-1.71) | 1 | ||
| SOFA score | 1.15 (1.09-1.21) | <0.001 | 1.06 (1.002-1.12) | 0.04 |
| INR | 1.06 (0.94-1.21) | 0.29 | ||
| Bilirubin | 1.05 (1.02-1.07) | <0.001 | ||
| Creatinine | 1.21 (1.06-1.4) | 0.005 | ||
| Albumin | 1.03 (0.95-1.11) | 0.46 | ||
| AKI at admission | 2.33 (1.46-3.71) | <0.001 | ||
| Sodium | 0.98 (0.96-1.008) | 0.23 | ||
| TLC | 1 | 0.002 | ||
| Proven infection | 2.01 (1.23-3.27) | 0.005 | ||
| Second infection | 1.91 (0.67-5.4) | 0.22 | ||
| H/o hospitalization | 2.2 (1.37-3.52) | 0.001 | ||
| Resistant organisms vs. nonresistant | 1.27 (0.57-2.83) | 0.54 | ||
| Presence of fever in last 7 days | 3.7 (2.12-6.41) | <0.001 | ||
| qSOFA positive | 3.19 (1.98-5.12) | <0.001 | ||
| Either fever or qSOFA or both | 3.45 (2.13-5.6) | <0.001 | 2.19 (1.27-3.76) | 0.005 |